Context

Blindness in children prevents their proper development, their well-being and access to education. In Peru, retinopathy of prematurity is the leading cause of infantile blindness. Yet in the majority of cases, simple access to eye care and good medical follow-up could avoid this. In the case of retinopahty, it has been proven that the cost of blindness far exceeds the cost of treatment, which represents one of the most cost-effective interventions in the area of eye health.

 

Supported project

In 2018, the L'OCCITANE Foundation and L'OCCITANE Peru supported Orbis International in preventing retinopathy in premature infants in the region of Lima and more generally in Peru as a whole. Thanks to this project, a system for the management of information was implemented within the neonatal intensive care departments of the public hospitals.

Thus, the medical staff was able to access the files of new-borns in real time and provide adequate care. What's more, the project aimed to disseminate expertise and the methods of treating the disease, so as to ensure a better quality of neonatal care in the country. Therefore, the project aimed to provide a better eye health framework for premature children in Lima and more generally in Peru.

Some figures

Budget 10.000 euros

Results 1.692 beneficiaries